Canada · 
Who invested in Gandeeva Therapeutics?
Gandeeva Therapeutics's investors include Lux Capital and Obvious Ventures.
Canada · Series A startup
Who invested in Gandeeva Therapeutics
Funding summaryUpdated 26 Oct 2026
$40Mraised across 1 round since 2022, from 1 source
- Latest round
- Series A, $40MJan 2022
- Investors
- 2
The rounds
- Jan 2022
Founders and team
From Gandeeva Therapeutics's own website: 1 founder, 6 on the team.
Sriram SubramaniamFounder & CEO
- Janet GeorgeExecutive Vice President of Artificial Intelligence of Mastercard
- David KarpChief Financial Officer
- Robert SikorskiChief Medical Officer Consultant
- Jay GaleotaDirector
- Shaq VaydaDirector
- Tom CeskaSenior Director, Structural Biology and Cryo-EM Operations
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Gandeeva Therapeutics
How much has Gandeeva Therapeutics raised?
Gandeeva Therapeutics has raised $40M across 1 round since 2022.
When did Gandeeva Therapeutics last raise?
Gandeeva Therapeutics's most recent round was a Series A of $40M in Jan 2022.
What was Gandeeva Therapeutics's biggest round?
Its most recent round, $40M in Jan 2022, is also its largest on record.
Who backed Gandeeva Therapeutics first?
Gandeeva Therapeutics's first round on record, in Jan 2022, was backed by Lux Capital and Obvious Ventures.
What stage is Gandeeva Therapeutics at?
Gandeeva Therapeutics's latest named round is a Series A, in Jan 2022.
Where is Gandeeva Therapeutics based?
Gandeeva Therapeutics is based in Canada.
Companies like Gandeeva Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.